Clinical Trial

Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to compare the efficacy of nebulized ketamine versus nebulized magnesium sulfate in reducing the incidence and severity of POST. * Primary outcome • To compare the incidence of POST method. * Secondary outcomes * Onset, Severity, and duration of POST at 0, 2, 4, 6, 12, 24 hours postoperative. * The hemodynamics recording (HR, BP, MBP, pre and post nebulization) * Adverse Effects (e.g., sedation, cough, nausea, vomiting, ….)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-24.
Trial Details
NCT Number NCT07381036
Lead Sponsor Sohag University
Conditions Postoperative Sore Throat
Enrollment 150 participants
Start Date 2026-02-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-03